Eribulin Mesylate Injection
Product Images NDC 70095-080

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 70095-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eribulin-carton (Carton)

Packaging label for Eribulin Mesylate Injection 1 mg/2 mL (0.5 mg/mL) sterile solution for intravenous use. The label includes dosage and use information, storage instructions, and a caution that the product is a cytotoxic agent. Labeler is Sun Pharmaceutical Industries, Inc. The label also shows the NDC 70095-080-01 and a barcode.*

FDA Label Image

Eribulin-figure-1 (Figure 1)

Kaplan-Meier survival curve chart titled 'Updated Overall Survival Analysis for Study 1' showing the proportion of patients alive over 36 months. Two groups are compared: Eribulin Mesylate (N=508) and Control (N=254). The chart includes time in months on the x-axis and proportion of patients alive on the y-axis, with a table below showing the number of patients at risk at various time points.*

FDA Label Image

Eribulin-figure-2 (Figure 2)

A Kaplan-Meier survival curve chart comparing overall survival probability over time (months) between Eribulin Mesylate and Dacarbazine in the liposarcoma stratum from Study 2. The chart shows survival probability on the y-axis and survival time in months on the x-axis, with Eribulin Mesylate represented by a solid line and Dacarbazine by a dashed line, along with subject counts at risk listed by time points below the graph.*

FDA Label Image

Eribulin-label (Label)

Label for Eribulin Mesylate Injection 1 mg/2 mL (0.5 mg/mL) sterile solution in a single-dose vial for intravenous use. Distributed by Sun Pharmaceutical Industries, Inc., the label includes storage instructions (20° to 25°C, with excursions permitted), a caution for cytotoxicity, and a barcode. The product is Rx only and made in China.*

FDA Label Image

Eribulin-structure (Str)

Chemical structure of eribulin mesylate depicted with atoms and bonds, including a mesylate group (CH3-SO3H) indicated by a dot.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.